226 related articles for article (PubMed ID: 12621497)
1. Split chimerism after allogeneic bone marrow transplantation in Chediak-Higashi syndrome.
Yamazaki S; Takahashi H; Fujii H; Miyamae T; Mori M; Fujioka K; Funabiki T; Yokota S; Arai N; Ikuta K
Bone Marrow Transplant; 2003 Jan; 31(2):137-40. PubMed ID: 12621497
[TBL] [Abstract][Full Text] [Related]
2. Chédiak-Higashi syndrome: hematopoietic chimerism corrects genetic defect.
Trigg ME; Schugar R
Bone Marrow Transplant; 2001 Jun; 27(11):1211-3. PubMed ID: 11551033
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic cell transplantation for Chediak-Higashi syndrome.
Eapen M; DeLaat CA; Baker KS; Cairo MS; Cowan MJ; Kurtzberg J; Steward CG; Veys PA; Filipovich AH
Bone Marrow Transplant; 2007 Apr; 39(7):411-5. PubMed ID: 17293882
[TBL] [Abstract][Full Text] [Related]
4. [Chediak-Higashi disease: a new case treated by bone marrow allograft].
Demory JL; Senlecq-Tack S; Decoster A; Duhamel M; Spyckerelle C; Vittu G; Cousin J; Fischer A; Griscelli C
Ann Pediatr (Paris); 1989 Jun; 36(6):387-9. PubMed ID: 2667428
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation in Chédiak-Higashi syndrome.
Möttönen M; Lanning M; Saarinen UM
Pediatr Hematol Oncol; 1995; 12(1):55-9. PubMed ID: 7703042
[TBL] [Abstract][Full Text] [Related]
6. [The accelerated phase of Chediak-Higashi syndrome].
Bejaoui M; Veber F; Girault D; Gaud C; Blanche S; Griscelli C; Fischer A
Arch Fr Pediatr; 1989 Dec; 46(10):733-6. PubMed ID: 2697195
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation from an HLA-matched unrelated donor for treatment of Chediak-Higashi syndrome.
Liang JS; Lu MY; Tsai MJ; Lin DT; Lin KH
J Formos Med Assoc; 2000 Jun; 99(6):499-502. PubMed ID: 10925557
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases.
Haddad E; Le Deist F; Blanche S; Benkerrou M; Rohrlich P; Vilmer E; Griscelli C; Fischer A
Blood; 1995 Jun; 85(11):3328-33. PubMed ID: 7756666
[TBL] [Abstract][Full Text] [Related]
9. Restoration of neutrophil and platelet function in feline Chediak-Higashi syndrome by bone marrow transplantation.
Colgan SP; Hull-Thrall MA; Gasper PW; Gould DH; Rose BJ; Fulton R; Blanquaert AM; Bruyninckx WJ
Bone Marrow Transplant; 1991 May; 7(5):365-74. PubMed ID: 2070146
[TBL] [Abstract][Full Text] [Related]
10. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose.
Koh CY; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2005 Apr; 11(4):252-9. PubMed ID: 15812390
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic stem cell transplantation for Chediak-Higashi syndrome.
Umeda K; Adachi S; Horikoshi Y; Imai K; Terui K; Endo M; Mitsui T; Kato K; Koh K; Kajiwara R; Ito R; Otsuka Y; Inoue M; Ishii E; Yabe H
Pediatr Transplant; 2016 Mar; 20(2):271-5. PubMed ID: 26511512
[TBL] [Abstract][Full Text] [Related]
13. Chediak-Higashi syndrome: a case report.
Jayaranee S; Menaka N
Malays J Pathol; 2004 Jun; 26(1):53-7. PubMed ID: 16190108
[TBL] [Abstract][Full Text] [Related]
14. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
[TBL] [Abstract][Full Text] [Related]
15. A case of Chediak-Higashi syndrome presented with accelerated phase could be treated effectively by unrelated cord blood transplantation.
Zhang Y; Gao Z; Yu X
Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28762620
[TBL] [Abstract][Full Text] [Related]
16. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
[TBL] [Abstract][Full Text] [Related]
17. Chediak-Higashi syndrome--a case report with ultrastructural and cytogenetic study.
Yasha TS; Vani S; Vasanth A; Augustus M; Ramamohan Y; Das S; Shankar SK
Indian J Pathol Microbiol; 1997 Jan; 40(1):75-9. PubMed ID: 9145619
[TBL] [Abstract][Full Text] [Related]
18. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
